Home > Insider Trading > Novelion Therapeutics Inc.

Novelion Therapeutics Inc. (NVLN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

Displaying 7

13D Filing: Broadfin Capital and Novelion Therapeutics Inc. (NVLN)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d...

Keep Reading →

March 21st, 2018 - Hedge Funds

13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

Novelion Therapeutics Inc. (NASDAQ:NVLN): Alex Denner's Sarissa Capital Management filed an amended 13D. You can check out Sarissa Capital Management's latest holdings and filings here.

Keep Reading →

March 20th, 2018 - Hedge Funds

13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f...

Keep Reading →

August 8th, 2017 - Hedge Funds

13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

Keep Reading →

July 3rd, 2017 - Hedge Funds

13G Filing: Armistice Capital and Novelion Therapeutics Inc. (NVLN)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...

Keep Reading →

May 24th, 2017 - Hedge Funds

13G Filing: Highbridge Capital Management and Novelion Therapeutics Inc. (NVLN)

As of the date hereof, Highbridge Capital Management, LLC, as the trading manager of Highbridge International LLC and Highbridge Tactical Credit & Convertibles Master Fund, L.P.

Keep Reading →

May 1st, 2017 - Hedge Funds